학술논문

Rescuing lung development through embryonic inhibition of histone acetylation
Document Type
article
Source
Science Translational Medicine. 16(732)
Subject
Biomedical and Clinical Sciences
Cardiovascular Medicine and Haematology
Clinical Sciences
Perinatal Period - Conditions Originating in Perinatal Period
Human Genome
Infant Mortality
Rare Diseases
Genetics
Orphan Drug
Pediatric
Digestive Diseases
Congenital Structural Anomalies
Lung
2.1 Biological and endogenous factors
Aetiology
Respiratory
Good Health and Well Being
Animals
Humans
Mice
Hypertension
Pulmonary
Histones
Acetylation
Hernias
Diaphragmatic
Congenital
Biological Sciences
Medical and Health Sciences
Medical biotechnology
Biomedical engineering
Language
Abstract
A major barrier to the impact of genomic diagnosis in patients with congenital malformations is the lack of understanding regarding how sequence variants contribute to disease pathogenesis and whether this information could be used to generate patient-specific therapies. Congenital diaphragmatic hernia (CDH) is among the most common and severe of all structural malformations; however, its underlying mechanisms are unclear. We identified loss-of-function sequence variants in the epigenomic regulator gene SIN3A in two patients with complex CDH. Tissue-specific deletion of Sin3a in mice resulted in defects in diaphragm development, lung hypoplasia, and pulmonary hypertension, the cardinal features of CDH and major causes of CDH-associated mortality. Loss of SIN3A in the lung mesenchyme resulted in reduced cellular differentiation, impaired cell proliferation, and increased DNA damage. Treatment of embryonic Sin3a mutant mice with anacardic acid, an inhibitor of histone acetyltransferase, reduced DNA damage, increased cell proliferation and differentiation, improved lung and pulmonary vascular development, and reduced pulmonary hypertension. These findings demonstrate that restoring the balance of histone acetylation can improve lung development in the Sin3a mouse model of CDH.